SOLUBLE RECOMBINANT ALFA V BETA 3-ATTACHED RECEPTOR

PROBLEM TO BE SOLVED: To obtain a new attached receptor, comprising a soluble recombinant αVβ3 -attached receptor having ligand-binding activities, concerning cell attachment, movement for clot formation, inflammation, embryogenesis, propagation and ectopia of cancer, etc., and useful for treatment,...

Full description

Saved in:
Bibliographic Details
Main Authors GUESSOW DETLEV, MEHTA RAJ, CULLEN EILISH, GOODMAN SIMON L, DIEFENBACH BEATE, BROWN ALEX
Format Patent
LanguageEnglish
Published 30.06.1998
Edition6
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:PROBLEM TO BE SOLVED: To obtain a new attached receptor, comprising a soluble recombinant αVβ3 -attached receptor having ligand-binding activities, concerning cell attachment, movement for clot formation, inflammation, embryogenesis, propagation and ectopia of cancer, etc., and useful for treatment, etc., by the inhibition against them. SOLUTION: This new attached receptor is a substantially purified and soluble recombinant αVβ3 -attached receptor having undamaged ligand-binding activities. The receptor is directly concerned with cell attachment, movement for clot formation; inflammation, embryogenesis, propagation and ectopia of cancer, etc., and is useful for development of a cancer-treating agent for inhibiting them, a molecular level study of the binding of a ligand and signal-transfer mechanism following thereto, etc. The attached receptor is obtained by integrating αV, chain cDNA of the receptor shortened by cutting off a part containing >=52 amino acids from the C-terminus, and β3 chain cDNA of the receptor shortened by cutting off a part containing >=61 amino acids from the C-terminus into a vector for transferring baculovirus, expressing the vector by infecting an insect cell by the baculovirus and culturing the insect cell, and separating and purifying the product.
Bibliography:Application Number: JP19970338883